In the context of the newly identified PD risk gene GPNMB, reported in 2022, it has been demonstrated that mutations in this gene lead to an increase in the quantity of α-synuclein within neurons (Weterman et al. 1995; Diaz-Ortiz et al. 2022). The gene discussed is SNCA; the disease is Parkinson disease.